Related Experiment Videos
Expression of the retinoblastoma gene product in renal tumors
J C Presti1, V E Reuter, C Cordon-Cardo
1Department of Urology, University of California, San Francisco, USA.
Background:
Alterations in the retinoblastoma (Rb) gene and its protein product have been detected in numerous solid tumor malignancies. Loss of Rb function is believed to contribute to neoplastic transformation or to the development of metastases. To define the role of Rb in renal cancer, we analyzed renal tumor specimens for molecular alterations in the Rb gene and for lack of Rb protein expression, and correlated the results to clinicopathological characteristics.
Materials And Methods:
Thirteen renal cancer cell lines, 62 primary renal tumors, and 5 metastatic renal cancers were studied by Southern blot analysis for defects in the Rb gene, and by immunohistochemistry for Rb protein expression. Results were correlated with histopathological parameters and patient survival.
Results:
Structural alterations in the Rb gene were not detects in any of the renal cancer cell line or primary renal tumors studied. A rearranged Rb gene was observed in 1/5 metastatic tumor specimens. Western blot analyses revealed a truncated Rb protein in one of 13 renal cancer cell lines; immunohistochemical analysis revealed Rb protein in all papillary and oncocytic tumors, and in 39/44 non-papillary tumors. Rb expression patterns did not correlate with pathological stage, histological grade or the development of metastatic disease.
Conclusion:
Molecular alterations of the Rb gene are infrequent (<2%) in renal cancers, and Rb protein is present in the majority of primary (92%) and metastatic (100%) renal tumors. Loss of Rb expression does not appear to significantly contribute to malignant transformation or progression of renal cancers.
Insights
Retinoblastoma (Rb) gene alterations are rare in kidney cancer. Rb protein is usually present, suggesting it doesn't significantly drive tumor growth or spread in renal cell carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The retinoblastoma (Rb) gene and its protein are implicated in various solid tumors.
- Loss of Rb function may promote cancer development and metastasis.
- Understanding Rb's role in renal cancer is crucial for targeted therapies.
Purpose of the Study:
- To investigate molecular alterations in the Rb gene in renal cancer.
- To assess Rb protein expression in renal tumors.
- To correlate Rb status with clinicopathological features and patient outcomes.
Main Methods:
- Analysis of 13 renal cancer cell lines, 62 primary tumors, and 5 metastatic samples.
- Southern blot analysis for Rb gene defects.
- Immunohistochemistry and Western blot for Rb protein expression.
Main Results:
- No structural Rb gene alterations found in cell lines or primary tumors; one rearrangement in metastatic samples.
- Truncated Rb protein detected in one cell line; Rb protein present in most primary (92%) and metastatic (100%) tumors.
- Rb expression did not correlate with tumor stage, grade, or metastasis.
Conclusions:
- Molecular Rb gene alterations are infrequent in renal cancers (<2%).
- Rb protein is expressed in the majority of renal tumors.
- Loss of Rb expression is not a significant factor in renal cancer development or progression.